Synthesis of Amphiphilic Copolymers of Poly(ethylene oxide) and Poly(ϵ‐caprolactone) with Different Architectures, and Their Role in the Preparation of Stealthy Nanoparticles
Source abstract
Abstract
Abstract Well‐defined copolymers of biocompatible poly(ϵ‐caprolactone) (PCL) and poly(ethylene oxide) (PEO) are synthesized by two methods. Graft copolymers with a gradient structure are prepared by ring‐opening copolymerization of ϵ‐caprolactone (ϵCL) with a PEO macromonomer of the ϵCL‐type. The ϵCL polymerization is initiated by a PEO macroinitiator to prepare diblock copolymers. These amphiphilic copolymers are used as stabilizers for biodegradable poly(D,L‐lactide) (PLA) nanoparticles prepared by a nanoprecipitation technique. The effect of the copolymer characteristic features (architecture, composition, and amount) on the nanoparticle formation and structure is investigated. The average size, size distribution, and stability of aqueous suspensions of the nanoparticles is measured by dynamic light scattering. For comparison, an amphiphilic random copolymer, poly(methyl methacrylate‐co‐methacrylic acid) (P(MMA‐co‐MA)), is synthesized. The stealthiness of the nanoparticles is analyzed in relation to the copolymer used as stabilizer. For this purpose, the activation of the complement system by nanoparticles is investigated in vitro using human serum. This activation is much less important whenever the nanoparticles are stabilized by a PEO‐containing copolymer rather than by the P(MMA‐co‐MA) amphiphile. The graft copolymers with a gradient structure and the diblock copolymers with similar macromolecular characteristics (molecular weight and hydrophilicity) are compared on the basis of their capacity to coat PLA nanoparticles and to make them stealthy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: biodegradable polymer synthesis and properties · Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Langer R. · Nature · 1998 · 392 · 5
2. A. J. Domb N. Kumar T. Sheskin A. Bentolila J. Slager D. Teomim inPolymeric Biomaterials(Ed: S. Dumitriu) Marcel Dekker New York2001 Ch. 4.
3. 10.1021/cr940351u10.1021/cr940351u ↗
4. 10.1080/02652040028843610.1080/026520400288436 ↗
5. 10.1016/S0169-409X(98)00039-810.1016/S0169-409X(98)00039-8 ↗
6. 10.1021/cm034519g10.1021/cm034519g ↗
7. 10.1016/S0142-9612(00)00393-810.1016/S0142-9612(00)00393-8 ↗
8. 10.1023/B:PHAM.0000033005.25698.9c10.1023/B:PHAM.0000033005.25698.9c ↗
9. 10.3109/0265204980900683110.3109/02652049809006831 ↗
10. 10.3109/0363904980910857110.3109/03639049809108571 ↗
11. H. Fessi J. P. Derissaguet F. Puisieux C. Thies FR 2 608 988 1988.
12. 10.1016/S0168-3659(02)00207-910.1016/S0168-3659(02)00207-9 ↗
13. 10.1016/S0927-7765(99)00156-310.1016/S0927-7765(99)00156-3 ↗
14. 10.1016/S0142-9612(03)00348-X10.1016/S0142-9612(03)00348-X ↗
15. 10.1016/S0168-3659(01)00390-X10.1016/S0168-3659(01)00390-X ↗
16. 10.1163/15685620175019530610.1163/156856201750195306 ↗
17. 10.1163/1568562036051114610.1163/15685620360511146 ↗
18. C. Passirani J. P. Benoit inBiomaterials for Delivery and Targeting of Proteins and Nucleic Acids(Ed: R. I. Mahato) CRC Boca Raton FL2005 Ch. 6.
19. 10.1016/0079-6700(95)00011-410.1016/0079-6700(95)00011-4 ↗
20. 10.1016/S0169-409X(02)00019-410.1016/S0169-409X(02)00019-4 ↗
21. 10.1163/15685620074363410.1163/156856200743634 ↗
22. 10.1016/0142-9612(95)00322-310.1016/0142-9612(95)00322-3 ↗
23. 10.1016/S0024-3205(97)00539-010.1016/S0024-3205(97)00539-0 ↗
24. 10.1016/S0024-3205(97)01175-210.1016/S0024-3205(97)01175-2 ↗
25. 10.1016/S0168-3659(97)00164-810.1016/S0168-3659(97)00164-8 ↗
26. 10.1021/la026339b10.1021/la026339b ↗
27. 10.1021/ma048768h10.1021/ma048768h ↗
28. J. Rieger P. Dubois R. Jérôme C. Jérôme Langmuir in press.
29. 10.1016/S0927-7765(02)00160-110.1016/S0927-7765(02)00160-1 ↗
30. P. Becker M. J. Schick Nonionic Surfactants: Physical Chemistry Surfactant Science Series Vol. 23 Marcel Dekker New York1987 pp. 435–491.
31. 10.1002/pola.1107210.1002/pola.11072 ↗
32. H. Fessi F. Puisieux J. P. Devissaguet Eur. Patent 274 961 1987.
33. 10.1007/BF0065928210.1007/BF00659282 ↗
34. 10.1016/0021-9797(77)90402-710.1016/0021-9797(77)90402-7 ↗
35. 10.1002/pi.498021010810.1002/pi.4980210108 ↗
36. 10.1016/S0927-7757(98)00524-X10.1016/S0927-7757(98)00524-X ↗
37. 10.1023/A:101193012756210.1023/A:1011930127562 ↗
38. 10.1016/0021-9797(91)90043-810.1016/0021-9797(91)90043-8 ↗
39. 10.1002/jbm.82029061010.1002/jbm.820290610 ↗
40. 10.1021/ma980995u10.1021/ma980995u ↗
41. 10.1016/j.jconrel.2004.04.02610.1016/j.jconrel.2004.04.026 ↗
42. M. M. Mayer inExperimental Immunochemistry(Eds: E. A. Kabat M. M. Mayer) Thomas Springfield IL1961 pp. 133–156.